Health Care & Life Sciences » Biotechnology | Cosmo Bio Co. Ltd.

Cosmo Bio Co. Ltd. | Cash Flow

Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
451,000.00
330,000.00
407,000.00
456,000.00
400,000.00
Depreciation, Depletion & Amortization
96,000.00
84,000.00
79,000.00
85,000.00
156,000.00
Other Funds
8,000.00
4,000.00
2,000.00
12,000.00
2,000.00
Funds from Operations
176,000.00
425,000.00
340,000.00
406,000.00
381,000.00
Changes in Working Capital
50,000.00
128,000.00
211,000.00
167,000.00
87,000.00
Net Operating Cash Flow
126,000.00
297,000.00
129,000.00
573,000.00
294,000.00
Capital Expenditures
71,000.00
70,000.00
175,000.00
252,000.00
546,000.00
Purchase/Sale of Investments
40,000.00
129,000.00
70,000.00
351,000.00
92,000.00
Net Investing Cash Flow
99,000.00
227,000.00
263,000.00
99,000.00
440,000.00
Cash Dividends Paid - Total
118,000.00
118,000.00
106,000.00
94,000.00
106,000.00
Net Financing Cash Flow
126,000.00
122,000.00
151,000.00
107,000.00
109,000.00
Net Change in Cash
97,000.00
52,000.00
285,000.00
550,000.00
264,000.00
Free Cash Flow
74,000.00
244,000.00
80,000.00
444,000.00
185,000.00
Other Sources
26,000.00
15,000.00
6,000.00
-
15,000.00
Change in Capital Stock
-
-
43,000.00
-
-
Exchange Rate Effect
2,000.00
-
-
15,000.00
9,000.00
Other Uses
14,000.00
43,000.00
24,000.00
-
-

About Cosmo Bio Co.

View Profile
Address
Toyo-Ekimae Building
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cosmobio.co.jp
Updated 09/14/2018
Cosmo Bio Co., Ltd. engages in export, import, and sale of bio-research reagents, instruments and software, and clinical diagnostics. Its products include research reagents for immunology, gene engineering, tissue culture, and biochemistry. The company was founded on August 25, 1983 and is headquartered in Tokyo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.